Amedeo's Top 20

Amedeo Smart

Independent Medical Education


02 May 2022

Multidisciplinary Journal Club

  1. Alyssa Fitzpatrick A, Cooper C, Vasilunas N, Ritchie B, et al.
    Describing the impact of maternal hyperimmune globulin and valaciclovir on the outcomes of CMV infection in pregnancy: a systematic review.
    Clin Infect Dis 2022.

  1. Provenzano M, Puchades M, Garofalo C, Jongs N, et al.
    Albuminuria-Lowering Effect of Dapagliflozin, Eplerenone, and their Combination in Patients with Chronic Kidney Disease: A Randomized Cross-over Clinical Trial.
    J Am Soc Nephrol 2022.

  2. De Miguel Z, Khoury N, Betley MJ, Lehallier B, et al.
    Exercise plasma boosts memory and dampens brain inflammation via clusterin.
    Nature 2021;600:494-499.

  3. Bislev LS, Wamberg L, Rolighed L, Grove-Laugesen D, et al.
    Effect of Daily Vitamin D3 Supplementation on Muscle Health: An Individual Participant Meta-analysis.
    J Clin Endocrinol Metab 2022;107:1317-1327.

  4. Levi LI, Sharma S, Schleiss MR, Furrer H, et al.
    Cytomegalovirus viremia and risk of disease progression and death in HIV-positive patients starting antiretroviral therapy.
    AIDS 2022.

  1. Furukawa K, Shima A, Kambe D, Nishida A, et al.
    Motor progression and nigrostriatal neurodegeneration in Parkinson's disease.
    Ann Neurol 2022.

  2. Bose G, Healy BC, Lokhande HA, Sotiropoulos MG, et al.
    Early predictors of clinical and MRI outcomes using LASSO in multiple sclerosis.
    Ann Neurol 2022.

  3. Pappa T, Ahmadi S, Bikas A, Hwang S, et al.
    Thyroid nodule shape independently predicts risk of malignancy.
    J Clin Endocrinol Metab 2022.

  4. Diebold M, Galli E, Kopf A, Sanderson N, et al.
    Immunological Predictors of Dimethyl Fumarate-Induced Lymphopenia.
    Ann Neurol 2022;91:676-681.

  5. Herbst RS, Majem M, Barlesi F, Carcereny E, et al.
    COAST: An Open-Label, Phase II, Multidrug Platform Study of Durvalumab Alone or in Combination With Oleclumab or Monalizumab in Patients With Unresectable, Stage III Non-Small-Cell Lung Cancer.
    J Clin Oncol 2022.

  1. Levine DA, Springer MV, Brodtmann A.
    Blood Pressure and Vascular Cognitive Impairment.
    Stroke 2022;53:1104-1113.

  2. Zeng X, Su Y, Tan A, Zou L, et al.
    The association of coffee consumption with the risk of osteoporosis and fractures: a systematic review and meta-analysis.
    Osteoporos Int 2022.

  3. Paparodis RD, Karvounis E, Bantouna D, Chourpiliadis C, et al.
    Large, slowly growing, benign thyroid nodules frequently coexist with synchronous thyroid cancers.
    J Clin Endocrinol Metab 2022.

  4. Andre F, Ismaila N, Allison KH, Barlow WE, et al.
    Biomarkers for Adjuvant Endocrine and Chemotherapy in Early-Stage Breast Cancer: ASCO Guideline Update.
    J Clin Oncol 2022.

  5. Chou R, Dana T, Brent GA, Goldner W, et al.
    Serum Thyroglobulin Measurement Following Surgery without Radioactive Iodine for Differentiated Thyroid Cancer: A Systematic Review.
    Thyroid 2022.

  1. Sarraj A, Parsons M, Bivard A, Hassan AE, et al.
    Endovascular Thrombectomy versus Medical Management in Isolated M2 Occlusions: Pooled Patient-Level Analysis from the EXTEND-IA Trials, INSPIRE and SELECT Studies.
    Ann Neurol 2022.

  2. Cramer SW, Do TH, Palzer EF, Naik A, et al.
    Persistent racial disparities in deep brain stimulation for Parkinson's disease.
    Ann Neurol 2022.

  3. Stafford AP, Hoskin TL, Day CN, Sanders SB, et al.
    Contemporary Axillary Management in cT1-2N0 Breast Cancer with One or Two Positive Sentinel Lymph Nodes: Factors Associated with Completion Axillary Lymph Node Dissection Within the National Cancer Database.
    Ann Surg Oncol 2022.

  4. de Boniface J, Frisell J, Kuhn T, Wiklander-Brakenhielm I, et al.
    False-negative rate in the extended prospective TATTOO trial evaluating targeted axillary dissection by carbon tattooing in clinically node-positive breast cancer patients receiving neoadjuvant systemic therapy.
    Breast Cancer Res Treat 2022.

  5. Davey MG, Cleere EF, O'Donnell JP, Gaisor S, et al.
    Value of the 21-gene expression assay in predicting locoregional recurrence rates in estrogen receptor-positive breast cancer: a systematic review and network meta-analysis.
    Breast Cancer Res Treat 2022.


more..


Privacy Policy